微管蛋白秋水仙碱位点抑制剂研究进展

陈静; 陶雪芬; 应华洲

引用本文:	陈静,陶雪芬,应华洲.微管蛋白秋水仙碱位点抑制剂研究进展[J].中国现代应用药学,2011,28(9):824-830.
	CHEN Jing,TAO Xuefen,YING Huazhou.Recent Development of Colchicine Binding Site Inhibitors[J].Chin J Mod Appl Pharm(中国现代应用药学),2011,28(9):824-830.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 4761次下载 4593次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
微管蛋白秋水仙碱位点抑制剂研究进展
陈静¹, 陶雪芬¹, 应华洲²
1.浙江中医药大学，杭州 310053;2.浙江仙琚制药技术开发有限公司，杭州 310005

摘要:

微管蛋白是细胞骨架的主要成分，参与了细胞过程的许多环节。秋水仙碱位点抑制剂(CSIs)是一类重要的微管蛋白聚合抑制剂。目前已经有许多CSIs作为抗肿瘤药物被发现或设计、合成，并取得了很大的进展。本研究主要就CSIs的作用机制、共同结构特征以及各种类型CSIs的构效关系作一综述。

关键词: 微管蛋白秋水仙碱位点抑制剂构效关系抗肿瘤

DOI：

分类号:

基金项目:

Recent Development of Colchicine Binding Site Inhibitors

CHEN Jing¹, TAO Xuefen¹, YING Huazhou²

1.Zhejiang Chinese Medicinal University, Hangzhou 310053, China;2.Zhejiang Xianju Pharmaceutical Technology Co., Ltd., Hangzhou 310005, China

Abstract:

Microtubules are cytoskeletal components which play important roles in a number of cellular processes. Colchicine binding site inhibitors (CSIs) is one of the major classes of tubulin polymerization inhibitors. Many CSIs have been discovered, designed or synthesized as anticancer agents in the past several years and great progress has been made. We discuss the insights gained so far relevant to the mechanism of CSIs and their common structures. The recent development of CSIs with their biological activity and structure-activity relationship is also reviewed.

Key words: microtubules colchicine binding site inhibitor structure-activity relationship anticancer